TimesSquare Capital Management LLC Cuts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

TimesSquare Capital Management LLC cut its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 20.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 223,298 shares of the company's stock after selling 58,182 shares during the quarter. TimesSquare Capital Management LLC owned about 0.26% of HealthEquity worth $18,277,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Truist Financial Corp increased its holdings in shares of HealthEquity by 7.0% during the second quarter. Truist Financial Corp now owns 2,864 shares of the company's stock valued at $247,000 after acquiring an additional 188 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its position in shares of HealthEquity by 3.9% during the first quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company's stock valued at $426,000 after buying an additional 197 shares during the last quarter. Nisa Investment Advisors LLC boosted its position in shares of HealthEquity by 7.5% during the second quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company's stock valued at $246,000 after buying an additional 198 shares during the last quarter. Elk River Wealth Management LLC boosted its position in shares of HealthEquity by 0.3% during the third quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company's stock valued at $5,417,000 after buying an additional 217 shares during the last quarter. Finally, CWM LLC boosted its position in shares of HealthEquity by 6.9% during the second quarter. CWM LLC now owns 3,958 shares of the company's stock valued at $341,000 after buying an additional 255 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Up 1.5 %

Shares of HQY stock traded up $1.45 during mid-day trading on Monday, hitting $100.27. The stock had a trading volume of 500,532 shares, compared to its average volume of 615,481. HealthEquity, Inc. has a 12-month low of $62.10 and a 12-month high of $100.97. The firm has a market capitalization of $8.76 billion, a P/E ratio of 83.56, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. The firm's 50-day moving average is $83.57 and its two-hundred day moving average is $80.60. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The business had revenue of $299.93 million during the quarter, compared to analysts' expectations of $284.48 million. On average, analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the topic of several recent analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $105.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Barrington Research reissued an "outperform" rating and issued a $105.00 target price on shares of HealthEquity in a research report on Friday, September 20th. Bank of America dropped their target price on HealthEquity from $105.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a "buy" rating in a research report on Wednesday, September 4th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $92.00 price objective on shares of HealthEquity in a research report on Wednesday, September 4th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $103.83.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the transaction, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Robert W. Selander sold 8,250 shares of the firm's stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the sale, the director now directly owns 4,823 shares of the company's stock, valued at approximately $387,093.98. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is owned by corporate insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.